Context Therapeutics Reports Full Year 2024 Operating and Financial Results

Go back to Context Therapeutics Reports Full Year 2024 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.53 +0.01 (1.92%)
Previous Close $0.52    52 Week High
Open $0.53    52 Week Low
Day High $0.55    P/E N/A 
Day Low $0.51    EPS
Volume 400,451